Third, as gain-of-function mutations in NLRP3 gene like R260W, D303G, and E311K cause autoinflammatory disease, CAPS, we need to assess the potential utilization of newly discovered substances as a treatment for CAPS patients by determining where they bind on NLRP3. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.